Trump Administration Finalizes Rule Cutting Off Medicaid and CHIP Funding for Trans Youth Health Care
A new CMS rule bars federal Medicaid and CHIP matching funds for gender-affirming care for anyone under 18, effective October 13. States can still cover it — just not with federal money.
The Centers for Medicare & Medicaid Services has finalized a rule that will strip federal funding from gender-affirming care for transgender minors covered by Medicaid and the Children’s Health Insurance Program, the agency confirmed this week. The rule takes effect October 13, and it marks one of the most consequential federal actions on trans health care since the current administration took office.
What the rule actually does
The regulation blocks federal matching funds for puberty-suppressing medication, cross-sex hormone therapy, and gender-affirming surgical procedures for Medicaid beneficiaries under 18 and CHIP beneficiaries under 19. States remain free to cover this care — Medicaid is a joint state-federal program — but they’ll have to do it entirely with their own money, since Washington will no longer reimburse its usual share.
For states that already restrict or ban this care for minors, the rule changes little in practice. For states that currently cover it, the math gets harder overnight: losing the federal match, which typically covers 50 to 77 percent of Medicaid costs depending on the state, turns a shared expense into one state legislatures will have to fund entirely on their own or eliminate.
CMS built in a narrow transition window. Young people already receiving hormone therapy can continue for up to six months under a “clinically managed tapering period,” rather than being cut off immediately. The rule also preserves Medicaid’s Early and Periodic Screening, Diagnostic, and Treatment benefit and CHIP mental health coverage, and it explicitly keeps coverage in place for related care like treatment for disorders of sexual development and management of complications.
The reaction
Health law and civil rights groups moved quickly to condemn the rule. Sarah Somers, legal director at the National Health Law Program, called it a disregard for “decades of research proving that gender-affirming care is safe, effective, and medically necessary,” warning that blocking access “will cause incalculable harm to trans and nonbinary youth.” Advocates for Trans Equality said the rule would “severely restrict access to transition-related care for transgender youth,” and Human Rights Campaign president Kelley Robinson argued that care decisions belong to young people, their families, and their doctors — “without politicians interfering.”
Every major U.S. medical association — the American Academy of Pediatrics, the American Medical Association, and the Endocrine Society among them — has said gender-affirming care for adolescents, when clinically appropriate, is safe and can be medically necessary. That consensus hasn’t moved the policy. Legal challenges from health advocacy and civil rights organizations are expected before the rule takes effect in October, following a familiar pattern: similar restrictions imposed by executive order and agency guidance over the past two years have drawn lawsuits in federal courts around the country, with mixed results.
Where this fits
This rule doesn’t exist in isolation. It follows a string of federal actions targeting trans health care access — from restrictions on gender-affirming care in federal prisons and for military servicemembers to the earlier fight over Medicaid coverage that Florida and other states had already litigated at the state level. What’s different here is the mechanism: rather than an executive order or a state ban, this is a formal CMS rule reshaping how the federal government finances Medicaid nationwide, which makes it considerably harder to unwind through a simple change in administration.
For trans youth and their families in states that had been covering this care through Medicaid, the practical effect will depend heavily on where they live. Blue states with the political will and budget room may backfill the funding themselves. Others won’t, and families in those states will be left choosing between paying out of pocket, traveling to another state, or stopping care.
The rule is final, but it isn’t the last word — expect litigation, and expect state legislatures to become the next battleground over who picks up the bill Washington just put down.
